Qianhui Pharmaceutical (Anhui) Co., Ltd., located in the Hefei Economic and Technological Development Zone, is an export-oriented enterprise jointly established by China Hong Kong and Japan (Daito Corporation and Nikko Trading Co., Ltd.). The company currently employs 220 people. It has established multifunctional production, hydrogenation production, purification, drying, and packaging workshops, as well as a bromination production workshop. Facilities include solid raw material warehouses, liquid raw material warehouses, finished product warehouses, and hazardous chemical warehouses. The company is equipped with a comprehensive office building, a research and experimental center, and an analysis and testing center. It possesses various advanced chemical production equipment, environmental protection equipment, and experimental instruments. A standardized wastewater treatment station with a daily processing capacity of 500 cubic meters has been constructed.

The company's annual export earnings exceed 18 million US dollars. Its main chemical production unit reactions include oxidation, hydrogenation (70 kg pressure), halogenation, acylation, esterification, condensation, cyclization, formylation, amination, diazotization, and azide reactions, among others. It specializes in the process development, production, and sales of pharmaceutical active ingredients and intermediates, including related import and export trade. The products are exported to international markets such as Japan, featuring high technological content, excellent quality, and stability.

The company maintains long-term, stable, and close cooperative relationships with national-level research institutions, universities, and Japanese pharmaceutical research organizations, with frequent mutual visits, exchanges, and collaborative activities. The enterprise boasts strong technical capabilities, advanced quality testing methods, comprehensive analytical equipment (GC, HPLC, IR, UV, etc.), a solid management foundation, high-quality products, and an excellent reputation. In 2009, it passed the ISO9001 international quality management system and ISO14000 environmental management system certifications, as well as the official GMP certification from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). In line with the company's development strategy, we are actively engaged in the applied development of biotech projects in cooperation with Japanese research institutions, preparing for the construction of new technology production lines, and planning pharmaceutical marketing. Development projects will cover new specialty health foods, functional health foods, daily chemicals, cosmetics, and other fields, with products targeting both domestic and international markets to meet the growing living and health needs of people.

The company advocates the philosophy of unity between people and enterprise, development and innovation, high quality and efficiency, integrity and cooperation, and mutual success. We warmly welcome talented individuals to join us and create a brilliant future together. We also sincerely look forward to cooperating with colleagues at home and abroad for common development.